標(biāo)題: Titlebook: Diabetic Retinopathy; Current Pharmacologi Michael W. Stewart Book 2017 Mayo Foundation for Medical Education and Research 2017 Alpha agoni [打印本頁] 作者: 有判斷力 時間: 2025-3-21 17:51
書目名稱Diabetic Retinopathy影響因子(影響力)
書目名稱Diabetic Retinopathy影響因子(影響力)學(xué)科排名
書目名稱Diabetic Retinopathy網(wǎng)絡(luò)公開度
書目名稱Diabetic Retinopathy網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Diabetic Retinopathy被引頻次
書目名稱Diabetic Retinopathy被引頻次學(xué)科排名
書目名稱Diabetic Retinopathy年度引用
書目名稱Diabetic Retinopathy年度引用學(xué)科排名
書目名稱Diabetic Retinopathy讀者反饋
書目名稱Diabetic Retinopathy讀者反饋學(xué)科排名
作者: 膠水 時間: 2025-3-21 20:19 作者: 占線 時間: 2025-3-22 02:52 作者: 展覽 時間: 2025-3-22 04:34 作者: entreat 時間: 2025-3-22 11:22
Héctor Wittwer,Daniel Sch?fer,Andreas Frewerathy has generally been considered a vasculopathy that results from breakdown of the blood-retinal barrier and closure of retinal capillaries. Recent evidence, however, suggests that DR begins as a neuro-retinopathy with vascular changes occurring later during the disease.作者: 打谷工具 時間: 2025-3-22 15:23
https://doi.org/10.1007/978-981-10-3509-8Alpha agonist; Anabolic steroid; Angiogenesis; Angiopoietin; Anti-VEGF; Corticosteroid; Dexamethasone; Fluo作者: 打谷工具 時間: 2025-3-22 18:09 作者: nautical 時間: 2025-3-22 23:04
The Diabetic Retina: Anatomy and Pathophysiology,athy has generally been considered a vasculopathy that results from breakdown of the blood-retinal barrier and closure of retinal capillaries. Recent evidence, however, suggests that DR begins as a neuro-retinopathy with vascular changes occurring later during the disease.作者: LINES 時間: 2025-3-23 02:23 作者: 使堅硬 時間: 2025-3-23 06:08
http://image.papertrans.cn/d/image/270486.jpg作者: 故意 時間: 2025-3-23 12:07 作者: evince 時間: 2025-3-23 15:10
Héctor Wittwer,Daniel Sch?fer,Andreas Frewerathy has generally been considered a vasculopathy that results from breakdown of the blood-retinal barrier and closure of retinal capillaries. Recent evidence, however, suggests that DR begins as a neuro-retinopathy with vascular changes occurring later during the disease.作者: esculent 時間: 2025-3-23 19:56
Todesfeststellung und Leichenschaum type 1 diabetes and the total number of patients affected with type 2 diabetes was much lower than it is today. The introduction of insulin in 1922 extended survival for patients with type 1 diabetes mellitus (DM), but life expectancy remained poor because many died of disease-related complication作者: nonradioactive 時間: 2025-3-24 00:30
Héctor Wittwer,Daniel Sch?fer,Andreas Freweretic retinopathy (PDR) – for several decades with level I evidence emerging from the Early Treatment of Diabetic Retinopathy Study [45] and the Diabetic Retinopathy Study (DRS) [166–168]. Laser reduced the risk of severe vision loss (<5/200) in eyes with PDR and moderate vision loss (>15 letters) in作者: deceive 時間: 2025-3-24 02:22 作者: 菊花 時間: 2025-3-24 07:07 作者: 歌劇等 時間: 2025-3-24 12:47
Transparenz und Rechenschaftslegungreference to both its consistency and biomechanical composition, the vitreous extends from the posterior lens capsule back to the retina’s internal limiting membrane (ILM). For centuries, ophthalmologists believed that the vitreous could not be safely manipulated, altered, or removed without precipi作者: 臆斷 時間: 2025-3-24 15:43
Luc Tayart de Borms,Emmanuelle Faure16 years. Dozens of drugs are in the development pipeline which will probably give us several new therapeutic options within the next decade. Development of new pharmacotherapeutic agents is being driven by several factors. Our understanding of the molecular pathways responsible for DR has improved,作者: 從容 時間: 2025-3-24 20:52
Der Bundesverband Deutscher Stiftungentreous have emerged as the preferred route of drug delivery for several reasons. Firstly, drug concentrations in the vitreous, retina, and choroid are higher after intravitreal injections than after any other route of administration. Secondly, the vitreous acts as a depot that slows drug elimination作者: aspersion 時間: 2025-3-25 01:17
Der Bundesverband Deutscher Stiftungenvisually impaired [6]. Vision impairment compromises quality of life by limiting physical activity, promoting social isolation, and causing dependence on others for the performance of many of life’s necessary functions [43]. Patients with diabetic macular edema (DME) also have higher rates of health作者: Palpate 時間: 2025-3-25 06:50
hy and systemic factors.A detailed discussion of the biochem.A well-illustrated and comprehensive analysis of the treatment of diabetic retinopathy, this book covers current treatment options and guidelines, whilst also providing a detailed discussion of emerging therapeutic targets.?..Existing ther作者: enchant 時間: 2025-3-25 11:09 作者: Instinctive 時間: 2025-3-25 14:13
Der Bundesverband Deutscher Stiftungen higher after intravitreal injections than after any other route of administration. Secondly, the vitreous acts as a depot that slows drug elimination from the eye and prolongs its duration of action. Thirdly, the small volume of injected drug results in low serum concentrations and may minimize the likelihood of systemic adverse events.作者: Palter 時間: 2025-3-25 17:23 作者: cardiovascular 時間: 2025-3-25 21:38
Treatment of Diabetic Retinopathy: A Historical Perspective,s. Since few patients lived long with DM, the incidence of diabetic retinopathy (DR) was low and early diagnosis and treatment were a low priority. In addition, only a small number of ophthalmologists served the population and their ability to accurately diagnose retinopathy was far more limited than it is today.作者: Precursor 時間: 2025-3-26 00:58
Corticosteroids: Targeting Multiple Cytokines and Chemokines,py for patients with inadequate responses after 3–6 months of monthly anti-VEGF injections [52, 66]. Supplemental laser usually resolves persistent edema slowly, but it has not been shown to incrementally improve VA in most cases [26, 62].作者: 一夫一妻制 時間: 2025-3-26 08:06 作者: 并置 時間: 2025-3-26 10:34
Vitreolysis: Targeting the Vitreoretinal Interface,tating catastrophic consequences such as retinal tears, retinal detachments, suprachoroidal hemorrhages, or endophthalmitis. In retrospect, it has become obvious that physicians lacked a sufficient understanding of vitreous anatomy and physiology and did not possess the proper technology with which to safely and effectively handle the vitreous.作者: 填料 時間: 2025-3-26 12:49 作者: 小說 時間: 2025-3-26 17:29 作者: cancellous-bone 時間: 2025-3-26 23:13 作者: 圓木可阻礙 時間: 2025-3-27 03:37
Safety Considerations of Pharmacotherapy, higher after intravitreal injections than after any other route of administration. Secondly, the vitreous acts as a depot that slows drug elimination from the eye and prolongs its duration of action. Thirdly, the small volume of injected drug results in low serum concentrations and may minimize the likelihood of systemic adverse events.作者: 美食家 時間: 2025-3-27 07:52 作者: Isolate 時間: 2025-3-27 10:58 作者: Commonplace 時間: 2025-3-27 15:19
https://doi.org/10.1007/978-3-476-05762-4py for patients with inadequate responses after 3–6 months of monthly anti-VEGF injections [52, 66]. Supplemental laser usually resolves persistent edema slowly, but it has not been shown to incrementally improve VA in most cases [26, 62].作者: SAGE 時間: 2025-3-27 21:38 作者: 高深莫測 時間: 2025-3-27 22:54 作者: Mutter 時間: 2025-3-28 05:01 作者: Classify 時間: 2025-3-28 06:34
Diabetes and Diabetic Retinopathy: Overview of a Worldwide Epidemic,ojected to continue to increase, reaching 8.3 billion people by 2013, with 13% of these people falling into the fastest-growing age group – those over the age of 65 [119]. The world’s changing demographic profile results from a remarkable transition in the causes of death. No longer are people prima作者: 簡略 時間: 2025-3-28 11:37
The Diabetic Retina: Anatomy and Pathophysiology,athy has generally been considered a vasculopathy that results from breakdown of the blood-retinal barrier and closure of retinal capillaries. Recent evidence, however, suggests that DR begins as a neuro-retinopathy with vascular changes occurring later during the disease.作者: 阻礙 時間: 2025-3-28 17:06
Treatment of Diabetic Retinopathy: A Historical Perspective,m type 1 diabetes and the total number of patients affected with type 2 diabetes was much lower than it is today. The introduction of insulin in 1922 extended survival for patients with type 1 diabetes mellitus (DM), but life expectancy remained poor because many died of disease-related complication作者: 孤獨無助 時間: 2025-3-28 18:46
Targeting Vascular Endothelial Growth Factor,etic retinopathy (PDR) – for several decades with level I evidence emerging from the Early Treatment of Diabetic Retinopathy Study [45] and the Diabetic Retinopathy Study (DRS) [166–168]. Laser reduced the risk of severe vision loss (<5/200) in eyes with PDR and moderate vision loss (>15 letters) in作者: interference 時間: 2025-3-29 00:16
Corticosteroids: Targeting Multiple Cytokines and Chemokines,ell to regimens that include repeated intravitreal injections. A significant minority of patients (approximately 40%), however, exhibit an inadequate response and require additional or alternate therapy. In the phase III anti-VEGF registration trials, laser photocoagulation served as secondary thera作者: 怕失去錢 時間: 2025-3-29 03:43
Current Treatment Recommendations,ore the introduction of potent pharmacotherapy for DR, early diagnosis of DR followed by prompt laser photocoagulation to eyes at risk of vision loss was the most effective way to stabilize vision [23]. Significant improvements in visual acuity (VA) were rarely achieved in patients with established
